
Loading, please wait...

Loading, please wait...

Atopic dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts the quality of life in young patients. While physicians often associate the disease with mood and anxiety disorders, the actual atopic dermatitis psychiatric burden leading to inpatient care has been less clear. A recently published study by Patel S et al. (2026) addressed this gap by reviewing the 2022 Kids' Inpatient Database to determine if adolescents with AD are more likely to be hospitalized for psychiatric reasons.
The research team identified 1,520 adolescent patients with atopic dermatitis and propensity-matched them with 7,634 controls. The primary objective was to assess if their reason for hospital admission was psychiatric. This category encompassed various conditions, including mood disorders, suicidal ideation, psychotic disorders, and eating disorders. Interestingly, psychiatric reasons accounted for 24.1% of admissions in the AD group, compared to 26.6% in the control group. The difference was not statistically significant (p = 0.2).
Furthermore, the multivariate analysis demonstrated that patients with AD did not have significantly higher odds of being admitted for psychiatric reasons compared to the control group. The adjusted Odds Ratio (aOR) stood at 0.87 (95% CI: 0.72-1.05). These results suggest that while the atopic dermatitis psychiatric burden may lead to psychological distress, it does not necessarily translate into severe disease progression requiring hospitalization in the adolescent demographic.
Although the risk of hospitalization may not be elevated, clinicians must remain vigilant regarding the mental health of their patients. Adolescence is a critical period for identity formation, and visible skin lesions can exacerbate social anxiety and depression. Therefore, dermatologists and pediatricians should incorporate routine mental health screenings into their practice. Effective management of pruritus and inflammation is essential to improving sleep and reducing psychological strain. In India, where stigmatization of skin conditions remains prevalent, patient counseling becomes even more vital for holistic care.
According to the latest research, adolescents with atopic dermatitis do not have significantly higher odds of being hospitalized for psychiatric reasons compared to those without the condition. However, they still face a higher risk of outpatient mental health challenges.
Common comorbidities include anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and sleep disturbances. While these may not always lead to hospitalization, they significantly impact daily functioning and quality of life.
Yes, experts recommend integrated care. Screening for psychological distress is crucial, as the chronic nature of eczema and social factors can lead to significant emotional burden even if hospitalization is not required.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between the reader and the author. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Patel S et al. Inpatient Psychiatric Burden in Adolescents With Atopic Dermatitis. Pediatr Dermatol. 2026 Feb 22. doi: 10.1111/pde.70165. PMID: 41723878.
Handa S et al. Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus. Dove Med Press. 2021 Nov 22.
Wan J et al. Severe Atopic Dermatitis Associated with Depression in Pediatric Patients. JAAD. 2021 Sep 02.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study assessing whether atopic dermatitis increases the risk of psychiatric hospitalization among adolescents, finding no significant difference in odds....
7 months ago

Subcutaneous infliximab provides stable steady-state pharmacokinetics and reduces immunogenicity in inflammatory bowel disease. This clinical review explores pivotal trial evidence, therapeutic drug monitoring recalibration, immunomodulator de-escalation, and real-world switching strategies.
Today

AIIMS Bathinda has inaugurated a specialized peritoneal oncology service featuring the RanD Performer 3 HIPEC platform. The facility offers cytoreductive surgery alongside hyperthermic intraperitoneal chemotherapy, transforming regional management for advanced ovarian, colorectal, and appendiceal malignancies.
Today

A cross-sectional study reveals that hypertension knowledge, illness perceptions, depression, and substance use significantly predict self-care behaviors. Addressing mental health and cognitive beliefs in primary care is crucial for optimal blood pressure control and cardiovascular disease prevention.
Today

This clinical overview examines recent advancements in lumbar disc herniation surgery, comparing microscopic and full-endoscopic discectomy while highlighting biportal techniques and emerging motion-preserving innovations for spine specialists.
Today

A breakthrough study reveals that loss of SELENOT in hypothalamic POMC neurons triggers premature cellular senescence, ATF6α stress activation, and ER calcium depletion, linking neuroendocrine decay to metabolic disease.
Today